<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Break a phase I/II outcome string into a list of cohort parts. — phase1_2_outcomes_to_cohorts • escalation</title><!-- favicons --><link rel="icon" type="image/png" sizes="96x96" href="../favicon-96x96.png"><link rel="icon" type="”image/svg+xml”" href="../favicon.svg"><link rel="apple-touch-icon" sizes="180x180" href="../apple-touch-icon.png"><link rel="icon" sizes="any" href="../favicon.ico"><link rel="manifest" href="../site.webmanifest"><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Break a phase I/II outcome string into a list of cohort parts. — phase1_2_outcomes_to_cohorts"><meta name="description" content="Break a phase I/II outcome string into a list of cohort parts.
Break a phase I/II outcome string into a list of cohort parts.
The outcome string describes the doses given, outcomes observed and the
timing of analyses that recommend a dose. The format of the string is
described in Brock _et al_. (2017).
The letters E, T, N &amp;amp; B are used to represents patients that experienced
(E)fficacy, (T)oxicity, (N)either and (B)oth. These letters are concatenated
after numerical dose-levels to convey the outcomes of cohorts of patients.
For instance, 2NET represents a cohort of three patients that were
treated at dose-level 2, one of whom experienced toxicity only, one that
experienced efficacy only, and one that had neither.
The results of cohorts are separated by spaces and it is assumed that a
dose-finding decision takes place at the end of a cohort. Thus,
2NET 1NN builds on our previous example, where the next cohort of two
were treated at dose-level 1 and neither of these patients experienced
either event See examples."><meta property="og:description" content="Break a phase I/II outcome string into a list of cohort parts.
Break a phase I/II outcome string into a list of cohort parts.
The outcome string describes the doses given, outcomes observed and the
timing of analyses that recommend a dose. The format of the string is
described in Brock _et al_. (2017).
The letters E, T, N &amp;amp; B are used to represents patients that experienced
(E)fficacy, (T)oxicity, (N)either and (B)oth. These letters are concatenated
after numerical dose-levels to convey the outcomes of cohorts of patients.
For instance, 2NET represents a cohort of three patients that were
treated at dose-level 2, one of whom experienced toxicity only, one that
experienced efficacy only, and one that had neither.
The results of cohorts are separated by spaces and it is assumed that a
dose-finding decision takes place at the end of a cohort. Thus,
2NET 1NN builds on our previous example, where the next cohort of two
were treated at dose-level 1 and neither of these patients experienced
either event See examples."><meta property="og:image" content="/logo.png"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">escalation</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.2.3</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/A100-DoseSelectors.html">Using escalation</a></li>
    <li><a class="dropdown-item" href="../articles/A205-CRM.html">CRM - Continual Reassessment Method</a></li>
    <li><a class="dropdown-item" href="../articles/A207-NBG.html">NBG - Neuenschwander, Branson &amp; Gsponer</a></li>
    <li><a class="dropdown-item" href="../articles/A210-TPI.html">TPI - Toxicity Probability Interval Design</a></li>
    <li><a class="dropdown-item" href="../articles/A220-mTPI.html">mTPI - Modified Toxicity Probability Interval Design</a></li>
    <li><a class="dropdown-item" href="../articles/A230-BOIN.html">BOIN - Bayesian Optimal Interval Design</a></li>
    <li><a class="dropdown-item" href="../articles/A280-TITE.html">TITE-CRM and TITE-NBG - Time-to-Event Designs</a></li>
    <li><a class="dropdown-item" href="../articles/A310-EfficacyToxicity.html">EffTox, Wages &amp; Tait, and BOIN12 - Efficacy &amp; Toxicity Designs</a></li>
    <li><a class="dropdown-item" href="../articles/A360-Combinations.html">BOIN-COMB - Treatment Combination Designs</a></li>
    <li><a class="dropdown-item" href="../articles/A600-DosePaths.html">Working with dose-paths</a></li>
    <li><a class="dropdown-item" href="../articles/A700-Simulation.html">Simulating dose-escalation trials</a></li>
    <li><a class="dropdown-item" href="../articles/A710-SimulationComparison.html">Comparing dose-escalation designs by simulation</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/brockk/escalation/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Break a phase I/II outcome string into a list of cohort parts.</h1>
      <small class="dont-index">Source: <a href="https://github.com/brockk/escalation/blob/HEAD/R/phase1_2_outcomes_to_cohorts.R" class="external-link"><code>R/phase1_2_outcomes_to_cohorts.R</code></a></small>
      <div class="d-none name"><code>phase1_2_outcomes_to_cohorts.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>Break a phase I/II outcome string into a list of cohort parts.</p>
<p>Break a phase I/II outcome string into a list of cohort parts.</p>
<p>The outcome string describes the doses given, outcomes observed and the
timing of analyses that recommend a dose. The format of the string is
described in Brock _et al_. (2017).</p>
<p>The letters E, T, N &amp; B are used to represents patients that experienced
(E)fficacy, (T)oxicity, (N)either and (B)oth. These letters are concatenated
after numerical dose-levels to convey the outcomes of cohorts of patients.
For instance, <code>2NET</code> represents a cohort of three patients that were
treated at dose-level 2, one of whom experienced toxicity only, one that
experienced efficacy only, and one that had neither.
The results of cohorts are separated by spaces and it is assumed that a
dose-finding decision takes place at the end of a cohort. Thus,
<code>2NET 1NN</code> builds on our previous example, where the next cohort of two
were treated at dose-level 1 and neither of these patients experienced
either event See examples.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">phase1_2_outcomes_to_cohorts</span><span class="op">(</span><span class="va">outcomes</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>


<dl><dt id="arg-outcomes">outcomes<a class="anchor" aria-label="anchor" href="#arg-outcomes"></a></dt>
<dd><p>character string representing the doses given, outcomes
observed, and timing of analyses. See Description.</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    <p>a list with a slot for each cohort. Each cohort slot is itself a
list, containing elements:
* <code>dose</code>, the integer dose delivered to the cohort;
* <code>outcomes</code>, a character string representing the <code>E</code>, <code>T</code>
<code>N</code> or <code>B</code> outcomes for the patients in this cohort.</p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Brock, K., Billingham, L., Copland, M., Siddique, S., Sirovica, M., &amp; Yap, C.
(2017). Implementing the EffTox dose-finding design in the Matchpoint trial.
BMC Medical Research Methodology, 17(1), 112.
https://doi.org/10.1186/s12874-017-0381-x</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="va">x</span> <span class="op">=</span> <span class="fu">phase1_2_outcomes_to_cohorts</span><span class="op">(</span><span class="st">'1NEN 2ENT 3TB'</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/length.html" class="external-link">length</a></span><span class="op">(</span><span class="va">x</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 3</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">1</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">dose</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 1</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">1</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">outcomes</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] "NEN"</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">2</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">dose</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 2</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">2</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">outcomes</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] "ENT"</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">3</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">dose</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 3</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">3</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">outcomes</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] "TB"</span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Kristian Brock, Daniel Slade, Michael Sweeting.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

    </footer></div>





  </body></html>

